Skip to content
OpenCapital
Get started

Doximity DOCS AFS and Trading Securities - Unrealized Loss Position Fair Value

AFS and Trading Securities - Unrealized Loss Position Fair Value at other companies

CVS Health logo
CVS HealthCVS
——

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-—
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0×0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's afs and trading securities - unrealized loss position fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's AFS and trading securities - unrealized loss position fair value?
Doximity (DOCS) reported AFS and trading securities - unrealized loss position fair value of $48.2M in Q4 2025.
How has Doximity's AFS and trading securities - unrealized loss position fair value changed year-over-year?
Doximity's AFS and trading securities - unrealized loss position fair value decreased by 71.1% year-over-year, from $166.81M to $48.2M.
What is the long-term trend for Doximity's AFS and trading securities - unrealized loss position fair value?
Over 2 years (2023 to 2025), Doximity's AFS and trading securities - unrealized loss position fair value has grown at a -47.9% compound annual growth rate (CAGR), from $653.37M to $177.3M.